Dennis Kucinich: Eminent domain should be used to prevent Ohio hospital closure

Dennis Kucinich, a Democratic candidate for governor of Ohio, is speaking out against Brentwood, Tenn.-based Quorum Health’s plan to close Affinity Medical Center, a 156-bed hospital in Massillon, Ohio, on Feb. 4.

Advertisement

Quorum, a spinoff of Franklin, Tenn.-based Community Health Systems, announced plans in early January to shut down the facility due to financial troubles. The company said declining revenues, increasing provider compensation and a competitive market caused Affinity Medical Center to record financial losses for the last six years.

Affinity Medical Center’s nurses rallied outside the facility Jan. 9 to seek support for keeping the hospital open. They were joined by Mr. Kucinich, who told those at the rally the city of Massillon can seek a restraining order to prevent the hospital closure. He said the city should look into eminent domain proceedings as a way to take over the hospital, according to the Cleveland Patch.

An Ohio Worker Adjustment and Retraining Notification Act notice dated Jan. 5 indicated 692 of Affinity Medical Center’s employees would be laid off by March 7. The closure will also result in 116 workers at Massillon-based Doctor’s Hospital Physician Services, which provides services at Affinity Medical Center, losing their jobs, according to a separate WARN notice.

More articles on legal and regulatory issues:

Former Allina VP charged with 7 counts of theft
8 latest healthcare industry lawsuits
Repeat physician imposter heads to prison: 7 things to know

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.